UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended March 31, 2016

 

or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

 

Commission File Number 000-09273

 

MOCON, INC.

(Exact name of registrant as specified in its charter)

 

Minnesota

41-0903312

(State or other jurisdiction of

(I.R.S. employer

incorporation or organization)

identification no.)

 

7500 Mendelssohn Avenue North, Minneapolis, Minnesota 55428

(Address of principal executive offices) (Zip code)

 

(763) 493-6370

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer (do not check if a smaller reporting company) ☐ Smaller reporting company ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

YES ☐ NO ☒

 

 

As of May 2, 2016, we had 5,794,000 common shares issued and outstanding.

 

 
 

 

 

MOCON, INC. AND SUBSIDIARIES

 

INDEX TO FORM 10-Q

For the Quarter Ended March 31, 2016

 

   

Page Number

PART I.        FINANCIAL INFORMATION

 
     
Item 1.

Financial Statements

 
 

Condensed Consolidated Balance Sheets March 31, 2016 (Unaudited) and December 31, 2015

1

     
 

Condensed Consolidated Statements of Income (Unaudited) Three-months ended March 31, 2016 and 2015

  2

     
  Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Three-months ended March 31, 2016 and 2015   3
     
 

Condensed Consolidated Statements of Cash Flows (Unaudited) Three-months ended March 31, 2016 and 2015

4

     
 

Notes to Condensed Consolidated Financial Statements (Unaudited)

5-11

     
Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12-20

     
Item 3

Quantitative and Qualitative Disclosures About Market Risk

20

     
Item 4.

Controls and Procedures

20-21

     
     

PART II.       OTHER INFORMATION

 
     
Item 1

Legal Proceedings

22

     
Item 1A

Risk Factors

22

     
Item 2.

Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

22

     
Item 3.

Defaults Upon Senior Securities

22

     
Item 4.  

Mine Safety Disclosures

22

     
Item 5.

Other Information

22

     
Item 6

Exhibits

23

     

Signatures

24

     

Exhibit Index

25

 

In this report, references to “MOCON,” “the Company,” “we,” “our,” or “us,” unless the context otherwise requires, refer to MOCON, Inc. and its subsidiaries.   All trademarks or trade names referred to in this report are the property of their respective owners.

 

 
 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MOCON, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(expressed in thousands, except share amounts)

 

   

March 31

         
   

2016

   

December 31,

 
   

(Unaudited)

   

2015

 
                 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 5,962     $ 6,344  

Trade accounts receivable, less allowance for doubtful accounts of $167 in 2016 and $141 in 2015

    10,228       8,786  

Other receivables

    161       326  

Inventories

    7,726       7,790  

Prepaid income taxes

    479       559  

Prepaid expenses, other

    1,194       897  

Total current assets

    25,750       24,702  
                 

Property, plant and equipment, net of accumulated depreciation of $8,630 in 2016 and $8,154 in 2015

    5,841       5,995  

Goodwill

    7,697       7,437  

Intangible assets, net

    8,999       8,986  

Other assets

    91       88  

Deferred income taxes

    216       211  

TOTAL ASSETS

  $ 48,594     $ 47,419  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

               

Current liabilities:

               

Current maturities of notes payable

  $ 63     $ 65  

Accounts payable

    3,411       3,033  

Accrued compensation and related expenses

    3,092       3,969  

Other accrued expenses

    1,068       811  

Accrued product warranties

    242       223  

Dividends payable

    637       637  

Deferred revenue

    1,383       862  

Total current liabilities

    9,896       9,600  
                 

Revolving lines of credit

    2,850       2,793  

Notes payable

    79       93  

Obligations to former employees

    36       34  

Deferred income taxes

    1,199       1,227  

Accrued income taxes

    201       201  

Total noncurrent liabilities

    4,365       4,348  

Total liabilities

    14,261       13,948  
                 

Shareholders' equity:

               

Capital stock – undesignated. Authorized 3,000,000 shares; none issued and outstanding in 2016 and 2015

    -       -  

Common stock – $0.10 par value. Authorized 22,000,000 shares; issued and outstanding 5,794,000 shares in 2016 and 5,792,126 shares in 2015

    579       579  

Additional paid-in capital

    7,616       7,412  

Retained earnings

    30,461       30,700  

Accumulated other comprehensive loss

    (4,323 )     (5,220 )

Total shareholders' equity

    34,333       33,471  
                 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

  $ 48,594     $ 47,419  

 

See accompanying notes to condensed consolidated financial statements.

 

 
-1-

 

 

MOCON, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited - expressed in thousands, except per share amounts)

 

   

Three Months Ended

 
   

March 31

 
   

2016

   

2015

 

Revenue:

               

Products

  $ 11,384     $ 12,169  

Services

    2,812       2,504  

Consulting

    534       687  

Total revenue

    14,730       15,360  
                 

Cost of revenue:

               

Products

    4,970       5,281  

Services

    1,174       1,053  

Consulting

    482       547  

Total cost of revenue

    6,626       6,881  
                 

Gross profit

    8,104       8,479  
                 

Selling, general and administrative expenses

    6,138       6,271  
                 

Research and development expenses

    1,203       1,069  
                 

Operating income

    763       1,139  
                 

Other income (expense), net

    (35 )     251  
                 

Income before income taxes

    728       1,390  
                 

Income tax expense

    240       482  
                 

Net income

  $ 488     $ 908  
                 

Net income per common share:

               

Basic

  $ 0.08     $ 0.16  

Diluted

  $ 0.08     $ 0.16  
                 

Weighted average common shares outstanding:

               

Basic

    5,797       5,742  

Diluted

    5,816       5,837  
                 

Cash dividends declared per common share

  $ 0.11     $ 0.11  

 

See accompanying notes to condensed consolidated financial statements.

 

 
-2-

 

 

MOCON, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited - expressed in thousands)

 

   

Three Months Ended

 
   

March 31

 
   

2016

   

2015

 
                 

Net income

  $ 488     $ 908  
                 

Other comprehensive income (loss):

               

Cumulative translation adjustment

    897       (2,713 )
                 

Comprehensive income (loss)

  $ 1,385     $ (1,805 )

 

See accompanying notes to condensed consolidated financial statements.  

 

 
-3-

 

 

MOCON, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited - expressed in thousands)

 

   

Three Months Ended

 
   

March 31

 
   

2016

   

2015

 

Cash flows from operating activities:

               

Net income

  $ 488     $ 908  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Share-based compensation expense

    186       161  

Change in fair value of derivative instrument

    -       11  

Loss on disposition of long-term assets

    18       6  

Depreciation and amortization

    689       605  

Deferred income taxes

    (171 )     (59 )

Excess tax benefit from employee stock plans

    -       (1 )

Changes in operating assets and liabilities:

               

Trade accounts receivable, net

    (1,233 )     (209 )

Other receivables

    174       (66 )

Inventories

    165       (441 )

Prepaid income taxes

    (345 )     237  

Prepaid expenses, other

    (222 )     (122 )

Accounts payable

    399       (1,312 )

Accrued compensation and related expenses

    (966 )     (464 )

Other accrued expenses

    121       312  

Accrued product warranties

    16       83  

Accrued income taxes

    276       255  

Deferred revenue

    498       890  

Net cash provided by operating activities

    93       794  
                 

Cash flows from investing activities:

               

Purchases of property, plant and equipment

    (137 )     (458 )

Proceeds from sale of property and equipment

    43       9  

Cash paid for patents and other intangible assets

    (8 )     (51 )

Other

    -       (1 )

Net cash used in investing activities

    (102 )     (501 )
                 

Cash flows from financing activities:

               

Proceeds from the revolving lines of credit

    850       5,843  

Payments on the revolving lines of credit

    (793 )     (5,858 )

Payments on notes payable and seller financed note payable

    (17 )     (232 )

Proceeds from the exercise of stock options

    19       106  

Excess tax benefit from employee stock plans

    -       1  

Dividends paid

    (637 )     (632 )

Net cash used in financing activities

    (578 )     (772 )
                 

Effect of exchange rate changes on cash and cash equivalents

    205       (553 )
                 

Net decrease in cash and cash equivalents

    (382 )     (1,032 )
                 

Cash and cash equivalents:

               

Beginning of period

    6,344       6,332  

End of period

  $ 5,962     $ 5,300  
                 

Supplemental disclosures of cash flow information:

               

Cash paid during the period for income taxes

  $ 205     $ 114  

Cash paid during the period for interest

  $ 26     $ 9  
                 

Supplemental schedule of noncash investing and financing activities:

               

Dividends accrued

  $ 637     $ 632  

Purchases of prepaid expenses, fixed assets and intangibles in accounts payable

  $ 142     $ 470  

Transfers of inventory to fixed assets

  $ 32     $ 10  

 

See accompanying notes to condensed consolidated financial statements.

 

 
-4-

 

 

MOCON, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED MARCH 31, 2016

(Unaudited)

 

Note 1 – Condensed Consolidated Financial Statements

 

The condensed consolidated balance sheet as of March 31, 2016, the condensed consolidated statements of income and comprehensive income (loss), for the three-months ended March 31, 2016 and 2015 have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim unaudited condensed consolidated financial statements reflect all adjustments which are, in the opinion of management, necessary to fairly present the financial position, results of operations and cash flows at March 31, 2016, and for all periods presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.

 

The results of operations for the three-month period ended March 31, 2016 are not necessarily indicative of operating results for the full year. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, previously filed with the Securities and Exchange Commission.

 

MOCON Inc. and its subsidiaries, develops, manufacturers and markets measurement, analytical, monitoring and consulting services for customers in the barrier packaging, food, pharmaceutical, consumer products, industrial hygiene, environmental, air quality monitoring, oil and gas exploration and other industries throughout the world.

 

We report our operating segments as Package Testing Products and Services (“Package Testing”), Permeation Products and Services (“Permeation”), and Industrial Analyzers Products and Services and Other (“Industrial Analyzers and Other”) for financial reporting purposes.

 

Principles of Consolidation

 

The consolidated financial statements include our accounts and our wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

 

Note 2 – Inventories

 

Inventories consist of the following (expressed in thousands):

 

   

March 31,

   

December 31,

 
   

2016

   

2015

 
                 

Finished products

  $ 1,555     $ 1,366  

Work-in-process

    2,280       2,375  

Raw materials

    3,891       4,049  
Total Inventory    $ 7,726     $ 7,790  

 

 

 
-5-

 

 

Note 3 – Net Income Per Common Share

 

Basic net income per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed using the treasury stock method to compute the weighted average common stock outstanding assuming the conversion of potential dilutive common shares.

 

The following table presents a reconciliation of the denominators used in the computation of net income per common share – basic, and net income per common share – diluted, for the three-months ended March 31, 2016 and 2015 (expressed in thousands):

 

   

Three Months Ended March 31,

 
   

2016

   

2015

 
                 

Weighted shares of common stock outstanding - basic

    5,797       5,742  

Dilutive impact of share-based awards

    19       95  

Weighted shares of common stock outstanding - diluted

    5,816       5,837  

 

Outstanding stock options totaling 666,235 and 145,200 for the three-months ended March 31, 2016 and March 31, 2015, respectively, were excluded from the net income per common share calculation because the shares would be anti-dilutive.

 

Note 4 – Goodwill and Intangible Assets

 

The changes in the carrying amount of goodwill for the three-month period ended March 31, 2016 were as follows (expressed in thousands):

 

   

Package

           

Industrial

         
   

Testing

   

Permeation

   

Analyzers & Other

   

Total

 
                                 

Balance as of December 31, 2015

  $ 4,967     $ 1,860     $ 610     $ 7,437  

Foreign currency translation

    198       62       -       260  

Balance as of March 31, 2016

  $ 5,165     $ 1,922     $ 610     $ 7,697  

 

 

We test goodwill for impairment annually at the reporting unit level using a fair value approach. We will perform our annual impairment test for goodwill in the fourth quarter or earlier if impairment indicators are identified.

 

 
-6-

 

 

Other intangible assets (all of which are being amortized except projects in process) are as follows (expressed in thousands):

 

   

As of March 31, 2016

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 
                         

Patents

  $ 1,874     $ (456 )   $ 1,418  

Trademarks and trade names

    3,455       (819 )     2,636  

Developed technology

    6,386       (2,838 )     3,548  

Customer relationships

    747       (332 )     415  

Internally developed software

    1,085       (181 )     904  

Other intangibles

    214       (136 )     78  
    $ 13,761     $ (4,762 )   $ 8,999  

 

 

   

As of December 31, 2015

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 
                         

Patents

  $ 1,844     $ (439 )   $ 1,405  

Trademarks and trade names

    3,321       (751 )     2,570  

Developed technology

    6,121       (2,551 )     3,570  

Customer relationships

    716       (298 )     418  

Internally developed software

    1,085       (154 )     931  

Other intangibles

    214       (122 )     92  
    $ 13,301     $ (4,315 )   $ 8,986  

 

 

Total amortization expense for the three-months ended March 31, 2016 and March 31, 2015 was $299,000 and $289,000, respectively. Projects in process are not amortized until the patent or trademark is granted by the regulatory agency or the asset is ready for use. Estimated amortization expense for the remainder of 2016 and each of the four succeeding fiscal years and thereafter based on the intangible assets as of March 31, 2016 is as follows (expressed in thousands):

 

2016

  $ 892  

2017

    1,161  

2018

    1,129  

2019

    1,125  

2020

    1,123  

2021 & Thereafter

    2,891  
    $ 8,321  

 

Note 5 – Accumulated Other Comprehensive Income (Loss)

 

Adjustments to accumulated other comprehensive income (loss) consist of the following (expressed in thousands):

 

   

Three Months Ended

 
   

March 31,

 
   

2016

   

2015

 

Beginning balance

  $ (5,220 )   $ (2,792 )

Foreign currency translation adjustments

    897       (2,713 )

Accumulated other comprehensive (loss)

  $ (4,323 )   $ (5,505 )

 

 
-7-

 

 

Note 6 – Warranty

 

We provide a warranty for most of our products. Warranties are for periods ranging from ninety days to one year, and cover parts and labor for non-maintenance repairs. Operator abuse, improper use, alteration, damage resulting from accident, or failure to follow manufacturer’s directions are excluded from warranty coverage.

 

Warranty expense is accrued at the time of sale based on historical claims experience. Generally, warranty reserves are also accrued for special rework campaigns for known major product modifications. We also offer extended warranty service contracts for select products when the factory warranty period expires.

 

Warranty provisions and claims for the three-months ended March 31, 2016 and March 31, 2015 were as follows (expressed in thousands):

 

   

Three Months Ended

 
   

March 31,

 
   

2016

   

2015

 

Beginning balance

  $ 223     $ 285  

Warranty provisions

    144       200  

Warranty claims

    (125 )     (131 )

Ending Balance

  $ 242     $ 354  

 

 

Note 7 – Debt

 

Notes payable consists of the following (expressed in thousands):

 

   

March 31,

2016

   

December 31,

2015

 
                 

Capital Leases

  $ 142     $ 158  

Less current portion of long-term notes payable

    63       65  

Total long-term notes payable

  $ 79     $ 93  

 

In the U.S., we have a $10.0 million secured revolving line of credit with a maturity date of August 26, 2018. Interest is charged monthly at one-month LIBOR (0.44 percent) plus 1.50 basis points which totaled 1.94 percent at March 31, 2016 and 1.74 percent at December 31, 2015. The line of credit is secured by our assets with the exception of the number of shares of outstanding stock of Dansensor that exceeds 65 percent of the shares outstanding. We had $2.9 million and $2.8 million outstanding on the line of credit at March 31, 2016 and December 31, 2015. Additionally, Dansensor has a DKK 10 million (approximately $1.5 million) available line of credit of which no amounts were outstanding as of March 31, 2016 and December 31, 2015 . Outstanding borrowings on the Denmark line of credit are charged interest at 4.35 percent per year.

 

We are subject to various financial and restrictive covenants in the bank Credit Agreement, including maintaining certain financial ratios and limits on incurring additional indebtedness, acquisitions, making capital and lease expenditures and making share repurchases. We are in compliance with our debt covenants at March 31, 2016 and expect to remain in compliance through the next twelve months .

 

 
-8-

 

 

As of March 31, 2016, the future minimum principal payments of the notes payable for the remainder of 2016 and each of the three succeeding fiscal years to the maturity of the note are as follows (expressed in thousands):

 

2016

  $ 49  

2017

    56  

2018

    37  
Total    $ 142  

 

Note 8 – Realignment Expenses

 

During 2015, we implemented a Realignment Plan in order to simplify our business structure by reducing the number of legal entities and by combining the sales and marketing teams of our Package Testing and Permeation segments under common leadership. As of December 31, 2015 approximately $483,000 was included in Accrued Compensation and related expenses and approximately $137,000 was included in Accounts payable on the consolidated balance sheet. During the three-months ended March 31, 2016 no additional amounts were expensed and cash payments were approximately $508,000 related to the Realignment Plan. As of March 31, 2016 approximately $112,000 is included in Accrued compensation and related expenses on the consolidated balance sheet and is expected to be paid by December 31, 2016.

 

Note 9 – Income Taxes

 

Our provision for income tax expense was 33 percent and 35 percent of income before income taxes for the three-months ended March 31, 2016 and March 31, 2015, respectively. The rate in the three-months ended of March 31, 2016 and March 31, 2015 were lower than the statutory rate due primarily to the effect of foreign operations where tax rates tend to be lower, the domestic manufacturing deduction and the research credit. The decrease in the effective tax rate for 2016 as compared to 2015 is primarily due to permanent enactment of the research and development credit whereby previously the related tax credit was not in the effective tax rate until enacted later in the year.

 

As of March 31, 2016 and December 31, 2015, the liability for gross unrecognized tax benefits was $187,000. With the exception of lapsing statutes of limitation it is expected that the amount of unrecognized tax benefits for positions which we have identified will not materially change in the next twelve months.

 

Note 10 – Share-Based Compensation

 

Stock Option Plans

 

As of March 31, 2016, we have reserved 374,957 shares of common stock for options and other share-based incentive awards that are still available for grant under our 2006 and 2015 stock incentive plans, and 782,160 shares for options that have been granted under either the 2006 or 2015 stock incentive plan. We issue new shares of common stock upon exercise of stock options.

 

 
-9-

 

 

Amounts recognized in the condensed consolidated financial statements related to share-based compensation are as follows (expressed in thousands):

 

   

Three Months Ended March 31,

 
   

2016

   

2015

 
                 

Total cost of share-based compensation

  $ 186     $ 161  

Amount of income tax benefit recognized in earnings

    -       (21 )

Amount charged against net income

  $ 186     $ 140  

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model (Black-Scholes). We use historical data to estimate the expected price volatility, expected option life and expected forfeiture rate. Our estimates are based on expected volatility for awards granted on daily historical trading data of our common stock for a period equivalent to the expected term of the award.

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. We estimate the expected term consistent with historical exercise and cancellation activity of its previous share-based grants with a seven or ten year as applicable contractual term. Forfeitures are based on historical experience. The dividend yield is calculated based upon the dividend payments made during the prior four quarters as a percent of the average stock price for that period.

 

A summary of the option activity for the first three months of 2016 is as follows (expressed in thousands, except share and per share amounts) :

 

                   

Weighted

         
           

Weighted

   

Average

   

Aggregate

 
           

Average

   

Remaining

   

Intrinsic

 
           

Exercise

   

Contractual

   

Value

 
   

Shares

   

Price

   

Term

   

(in thousands)

 
                                 

Options outstanding, December 31, 2015

    797,378     $ 14.91       4.7     $ 453  

Granted

    -       -       -       -  

Exercised

    (2,600 )     11.09       -       -  

Cancelled or expired

    (12,618 )     15.58       -       -  

Options outstanding, March 31, 2016

    782,160     $ 14.92       4.5     $ 261  

Options exercisable, March 31, 2016

    497,485     $ 14.91       3.3     $ 252  

 

The total intrinsic value of options exercised was $7,000 and $142,000 during the three-months ended March 31, 2016 and March 31, 2015, respectively.

 

As of March 31, 2016, there was $769,000 of total unrecognized compensation cost related to unvested share-based compensation granted under our plans. That cost is expected to be recognized over a weighted-average period of 0.9 years. The total fair value of option shares vested during the three-months ended March 31, 2016 and March 31, 2015 was zero and $88,000, respectively.

 

Employee Stock Purchase Plan

 

On May 27, 2015, our shareholders approved the 2015 Employee Stock Purchase Plan (“Purchase Plan”) whereby 50,000 shares of common stock will be available for future sale. The first offering period began on January 1, 2016 and provides participants an option to purchase shares of our common stock at a price per share equal to 85 percent of the value of the share of common stock at the beginning or end of the offering period (whichever is less).

 

 
-10-

 

 

Note 11 – Business Segments

 

We have four operating segments, structured by differences in products and services, that are regularly reviewed by our chief operating decision maker to make decisions about allocating resources and assessing segment performance. The segment performance is evaluated at segment operating income which is defined as gross profit less selling, general and administrative expenses and research and development expenses. General corporate expenses, including costs associated with various support functions such as human resources, information technology, finance and accounting, and general and administrative costs, are allocated to the reportable segments primarily on the basis of segment gross margin. Our four operating segments have been aggregated into three reportable segments. We aggregated our Other Products and Services operating segment into the Industrial Analyzers Products and Services segment based on minimal business activity and materiality.

 

The Package Testing segment provides customers with the ability to assess package performance, shelf-life, package improvement, cost reduction, sustainability and product safety using Modified Atmosphere Packaging and other technologies. The Permeation segment includes instruments and services that measure the rate at which various gases and vapors permeate through a variety of materials. The Industrial Analyzers and Other segment includes advanced gas analysis and monitoring instrumentation used in applications such as oil and gas exploration, beverage and specialty gas analysis, industrial hygiene and safety, food safety, environmental air monitoring and homeland security.

 

The accounting policies of the reportable segments are the same as those described in Note 1 to the Consolidated Financial Statements found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Intersegment revenue for the three months ended March 31, 2016 and March 31, 2015 were insignificant.

 

Financial information by reportable segment for the three-months ended March 31, 2016 and March 31, 2015 is as follows (expressed in thousands):

 

   

Three Months Ended

March 31, 2016

 
   

Revenue

   

Operating

Income (loss)

 

Package Testing

  $ 7,002     $ 847  

Permeation

    5,283       306  

Industrial Analyzers and Other

    2,445       (390 )

Total

  $ 14,730     $ 763  

 

 

   

Three Months Ended

March 31, 2015

 
   

Revenue

   

Operating

Income (loss)

 

Package Testing

  $ 6,756     $ 887  

Permeation

    6,102       678  

Industrial Analyzers and Other

    2,502       (426 )

Total

  $ 15,360     $ 1,139  

 

 
-11-

 

 

Item 2.      Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Management’s Discussion and Analysis provides material historical and prospective disclosures intended to enable investors and other users to assess our financial condition and results of operations. Statements that are not historical are forward-looking and involve risks and uncertainties discussed below under the caption “Forward-Looking Statements.” The following discussion of the results of operations and financial condition of MOCON should be read in conjunction with our consolidated financial statements and the related notes thereto included elsewhere in this report.

 

Overview

 

Description of Business

 

MOCON, Inc. designs, manufactures, markets and services products and provides consulting and testing services primarily in the measurement and analytical instrument and services markets. Our products include instruments that detect, measure and monitor gases and chemical compounds. We continually seek growth opportunities through technological and product improvement, by developing new products, and by acquiring new companies, new product lines, or rights to technologies.

 

We are headquartered in Minnesota and have operating locations in Minnesota, Denmark, and Colorado. We have offices and laboratories in Texas, Germany, France, Italy, Spain and China. We use a mix of a direct sales force and independent sales representatives to market our products and services in the United States, Canada, Europe and China, and we use a network of independent sales representatives and distributors to market and service our products and services in most other foreign countries.

 

Our ongoing plans for growth include continued substantial funding for research and development to drive new product introductions, together with strategic acquisitions and investments where appropriate.

 

Products and Services

 

Package Testing Products and Services

 

We manufacture and sell three primary products in this group: headspace analyzers, leak detection equipment and gas mixers. Our headspace analyzer products are used to analyze the amount and type of gas present in the headspace of flexible and rigid packages, as applied to gas flushing in modified or controlled atmosphere packaging. The principal market for these products consists of packagers of foods, beverages and pharmaceuticals. Our headspace analyzer products include the PAC CHECK®, CheckMateTM and CheckPointTM series of off-line headspace analyzers and the MAP Check 3TM series of on-line analyzers for continuous and intermittent monitoring of Modified Atmosphere Packaging (MAP) and other gas flushing operations.

 

Our leak detection products detect leaks in sterile medical trays, food pouches, blister packs and a wide range of other sealed packages. We currently manufacture three types of leak detection instruments. The first type is a non-destructive leak detector that senses small amounts of carbon dioxide escaping from a package or tray. The second type of instrument detects leaks and checks for seal integrity by applying and measuring pressure within a package. The third type pulls a vacuum on a package and looks for vacuum or gas flow changes. The principal markets for these products are packagers of sterile medical items, pharmaceuticals and food products. Our leak detection products include the LeakMatic IITM and LeakPointer IITM series of instruments.

 

Our gas mixers are used in the food production environment to assure that the package has been properly flushed with the correct mixture of gases. Our gas mixer products include the MAP Mix Provectus and MAP Mix 9001 on-line instruments.

 

 
-12-

 

 

Permeation Products and Services


Our permeation products consist of systems and services that measure the rate at which various gases and vapors transmit through a variety of materials. These products perform measurements under precise temperature, pressure and relative humidity conditions. The principal market for these products consists of manufacturers of packaging materials, including manufacturers of papers, plastic films, coatings and containers and the users of such packaging materials, such as companies in the food, beverage, pharmaceutical and consumer product industries. Other customers include manufacturers of flat panel displays, solar panels, electronics, and many other sophisticated materials.

 

We also provide certain laboratory testing services to companies that have a need for permeation data. These services consist primarily of testing film and package permeation for companies that:

 

 

wish to outsource their testing needs to us;

 

are interested in evaluating our instrumentation prior to purchase; or

 

have purchased our products but have a need for additional capacity.

 

Permeation instruments that we currently manufacture include OX-TRAN® systems for oxygen transmission rates, PERMATRAN-W® systems for water vapor transmission rates, and PERMATRAN-C® systems for carbon dioxide transmission rates. Our AQUATRAN® ultra-high sensitivity, trace moisture permeation analyzer has been increasingly accepted as the standard test instrument of choice in the flat panel, solar cell and electronics industries. Our systems are available in a wide range of options for our customers, including high or low throughput, price, sensitivity and ease of use. They are primarily marketed to research and development departments, as well as production and quality assurance groups.

 

Industrial Analyzers Products and Services and Other

 

We manufacture and distribute advanced gas analysis and monitoring instrumentation used in applications such as oil and gas exploration, process and beverage gas analysis, industrial hygiene, safety, environmental air monitoring and indoor air quality.

 

In this group, we manufacture and sell two types of gas analyzer instruments: gas chromatographs (GCs) and total hydrocarbon analyzers (THAs). These instruments are typically installed in fixed locations at the monitoring sites and perform their functions of detecting and measuring various gases continually or at regular intervals. We also make miniaturized gas sensors and detectors which are sold to original equipment manufacturers (OEMs) of mobile gas safety equipment.

 

Our industrial analyzer products, sensors and detectors are for use in industrial hygiene (detection of hazardous gases in the workplace), hydrocarbon gas analysis for oil and gas exploration, contaminant detection in the manufacture of specialty gases, and environmental monitoring (tracking the release, or the presence, of toxic substances). Our newest GC offering measures trace levels of contaminants in beverage grade carbon dioxide which is used to carbonate soft drinks, beer and water.

 

We market some of these products under the names PetroAlert®, piD-TECH®, and BevAlert®.

 

Microbial Detection Products

 

Our microbial detection products are designed to rapidly detect microbial growth in food and beverage samples. Using the total viable count (TVC) method, our GreenLight® series of instruments perform rapid and precise measurements to determine the presence or absence of aerobic bacteria in food products or ingredients. There are two models of the GreenLight product line currently available; the Greenlight 930 and the Greenlight 910.

 

 
-13-

 

 

Results of Operations

 

The following table sets forth the relationship between various components of our results of operations, stated as a percent of revenue, for the three-months ended March 31, 2016 and 2015:

 

   

Three Months Ended

March 31,

 
   

2016

   

2015

 
                 

Revenue

    100.0       100.0  

Cost of revenue

    45.0       44.8  

Gross profit

    55.0       55.2  

Selling, general and administrative expenses

    41.7       40.8  

Research and development expenses

    8.2       7.0  

Operating income

    5.1       7.4  

Other income (expense), net

    (0.2 )     1.6  

Income before income taxes

    4.9       9.0  

Income tax expense

    1.6       3.1  

Net income

    3.3       5.9  

 

 

Comparison of Financial Results for the Three -Months Ended March 31, 2016 to March 31, 2015

 

Revenue

 

Total revenue for the three-months ended March 31, 2016 was $14.7 million, which is 4 percent lower compared to $15.4 million reported in the same period in 2015. The revenue decline is due to a decrease in revenue of 13 percent and 2 percent for the Permeation and Industrial Analyzers and Other segment, respectively, offset by continued growth of 4 percent for the quarter in the Package Testing segment.

 

Revenue to foreign customers for the three-months ended March 31, 2016 and 2015, respectively, amounted to 68 percent and 67 percent of total consolidated revenue.

 

 

The following table summarizes total revenue by reporting segments for the three-months ended March 31, 2016 and 2015 (expressed in thousands):

 

   

Three Months Ended March 31,

 
             
   

2016

   

2015

 

Package Testing

  $ 7,002     $ 6,756  

Permeation

    5,283       6,102  

Industrial Analyzers and Other

    2,445       2,502  

Total Sales

  $ 14,730     $ 15,360  

 

 
-14-

 

 

The following table sets forth the relationship between various components of domestic and foreign revenue for the three-months ended March 31, 2016 and March 31, 2015 (expressed in thousands):

 

   

Three Months Ended March 31,

 
   

2016

   

2015

 

Domestic Revenue

  $ 4,642     $ 5,010  

Foreign Revenue:

               

Europe

    6,434       6,269  

Asia

    2,876       3,079  

Other

    778       1,002  

Total Foreign Revenue

    10,088       10,350  

Total Revenue

  $ 14,730     $ 15,360  

 

Package Testing Products and Services – Revenue in our Package Testing segment increased 4 percent for the three-months ended March 31, 2016, compared to the same period in the prior year, and accounted for 48 percent and 44 percent of our consolidated first quarter revenue in 2016 and 2015, respectively. The increase is due to an increase in demand for our on-line and mixer products as compared to the prior year period. Revenue from foreign destinations comprised 76 percent and 74 percent of total revenue in this segment for the three-months ended March 31, 2016 and March 31, 2015, respectively.

 

 

Permeation Testing Products and Services – Revenue in our Permeation segment decreased 13 percent for the three-months ended March 31, 2016 compared to the same period in the prior year, and accounted for 36 percent and 40 percent of our consolidated first quarter revenue in 2016 and 2015, respectively. The decrease in the current period is largely attributable to decreased sales in the domestic markets for instrumentation and a decline in consulting service revenue. In addition, we believe the decline was driven by the sales force realignment as we combined our sales and marketing teams for Permeation and Package Testing as announced during the fourth quarter of 2015.  Foreign revenue comprised 71 percent and 64 percent of the shipments in this segment in the first quarter of 2016 and 2015, respectively.

 

 

Industrial Analyzers Products and Services and Other – Revenue in our Industrial Analyzers and Other segment, which accounted for 16 percent for both of our consolidated first quarter revenue in 2016 and 2015, decreased 2 percent during the first quarter 2016 when compared to the same period in 2015. Revenue in this segment is comprised mainly of instruments, sensors and services provided by our Industrial Analyzer products. The decline in revenue for the three month period ended March 31, 2016 compared to the prior year period was due to the continued declines in the oil and gas exploration markets. The declines experienced from the oil and gas exploration markets was offset by an increase in revenue of approximately $0.5 million from our OEM sensor and detectors, which are primarily used in environmental monitoring and worker safety applications , which impacted the domestic and foreign revenue mix.  Revenue to foreign destinations comprised 40 percent and 57 percent of total revenue in this segment for the three-months ended March 31, 2016 and 2015, respectively.

 

Gross Profit

 

For both the three-months ended March 31, 2016 and 2015, the consolidated gross profit margins were 55 percent. The gross profit as a percentage of revenue for our Package Testing segment increased by four percentage points to 58 percent in the current quarter, compared to 54 percent in the prior year quarter, due to an  increased volume and organizational changes as part of our process improvement initiatives.  The gross profit as a percentage of revenue in the Permeation segment decreased to 57 percent from 59 percent as compared to the prior year quarter due to a decline in the volume of consulting revenue of which is supported primarily by a fixed cost structure. Gross profit as a percentage of revenue for the Industrial Analyzers and Other segment for the current quarter declined by five percentage points to 44 percent compared to 49 percent in the prior year quarter, due to an increase in the volume of OEM sensor and detector related revenue which are lower margin products than instruments.

 

 
-15-

 

 

We expect future gross profit percentages to fluctuate depending on the mix of product, service and consulting revenue and the impact of foreign currency fluctuations.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative (SG&A) expenses were $6.1 million, or approximately 42 percent of consolidated revenue, in the three-months ended March 31, 2016, compared to $6.3 million, or approximately 41 percent of consolidated revenue, in the same period of 2015. The dollar decrease in the current quarter was primarily related to cost reductions from our previously announced Realignment Plan which were offset in part by increased professional fees, new hires made throughout April to December 2015, and accrued severance.

 

Research and Development Expenses

 

Research and development (R&D) expenses were $1.2 million, or 8 percent of consolidated revenue in the first quarter 2016, compared to $1.1 million, or 7 percent of revenue in the same period of 2015. The spending levels described above are within our planned level of spending which we project to be between 6 percent and 8 percent of revenue each year.

 

Other Income (Expense), net

 

Other income (expense), net for the three-months ended March 31, 2016 and 2015 was as follows (expressed in thousands):

 

   

Three Months Ended

March 31,

 
   

2016

   

2015

 
                 

Interest expense

  $ (26 )   $ (27 )

Foreign currency exchange gain (loss)

    (9 )     278  

Total other income (expense)

  $ (35 )   $ 251  

 

The three months ended March 31, 2015 foreign currency exchange gain of $278,000 was primarily a result of the timing of payments made in foreign currencies during the first quarter of 2015 for payables incurred prior to the strengthening of the U.S. dollar.  During 2016, foreign currency exchange rates have not experienced significant fluctuations as compared to 2015.

 

Income Tax Expense

 

Our provision for income tax expense was 33 percent and 35 percent of income before income taxes for the three months ended March 31, 2016 and 2015, respectively. The rates in the three-months of 2016 and 2015 were lower than the statutory rate due primarily to the effect of foreign operations where tax rates tend to be lower, the domestic manufacturing deduction and the research credit. The decrease in the effective tax rate for 2016 as compared to 2015 is primarily due to permanent enactment of the research and development credit whereas previously the related tax credit was not in the effective tax rate until enacted later in the year.

 

Based on current projected annual operating results, current income tax rates, and current legislation, we expect the effective tax rate for the remainder of 2016 to be consistent with our experience in the first three-months. The overall effective tax rate may fluctuate over time based on the income tax rates in the various jurisdictions in which we operate, and also the level of pre-tax profits in each of these jurisdictions.

 

 
-16-

 

 

Operating Income and Net Income

 

Operating income was $763,000 million in the first quarter 2016 compared to $1.1 million in the first quarter of 2015. The decline in the three-month periods is primarily due to the decline in gross profit contribution as discussed above.

 

Net income was approximately $488,000 in the first quarter 2016, compared to a net income of approximately $908,000 in the first quarter 2015. Diluted net income per share was $0.08 and $0.16 in the three-months ended March 31, 2016 and March 31, 2015, respectively.

 

Liquidity and Capital Resources

 

Total cash and cash equivalents decreased $382,000 to $6.0 million during the three-months ended March 31, 2016, compared to $6.3 million at December 31, 2015. Of the March 31, 2016 balance, $5.5 million was held outside of the United States. The year-to-date decrease in cash and cash equivalents was primarily due to dividend payments of $637,000 and purchases of property, plant and equipment totaling $137,000, and payments related to the Realignment Plan of $508,000, offset by cash provided from operations of approximately $93,000. Of the $10.0 million available, we had $2.9 million and $2.8 million, respectively, outstanding on the revolving lines of credit as of March 31, 2016 and December 31, 2015. The U.S. revolving line of credit accrues interest at 1.50 percent over the one-month LIBOR rate, which totaled 1.94 percent at March 31, 2016. The revolving line of credit related to our U.S. borrowings are due on August 26, 2018, and we are subject to certain financial and restrictive covenants.

 

Our working capital, current assets minus current liabilities, increased by $752,000 to $15.8 million compared to $15.1 million as of March 31, 2016 and December 31, 2015, respectively. Our cash and cash equivalents balance was positively impacted during the three-months ended March 31, 2015 by approximately $205,000 due to the currency rate fluctuations.

 

One of our strategic objectives is, as market and business conditions warrant, to consider acquisitions of, or investments in, businesses, products and/or technologies. If we wish to pursue one or more additional acquisition opportunities, this may require the consent of the Bank under the credit agreement we have executed, and we may need to fund such activities with a portion of our cash balances and debt or equity financing. If we need to raise additional capital, an equity-based or equity-linked financing may be used which could be dilutive to existing shareholders. If we raise additional funds by issuing debt, we may be subject to additional restrictive covenants that could limit our operational flexibility and higher interest expense could dilute earnings per share.

 

 

We may invest a portion of our available cash in highly liquid marketable securities consisting primarily of certificates of deposits, municipal bonds, and money market funds. Our investment policy is to manage these assets to preserve principal, maintain adequate liquidity at all times, and maximize returns subject to investment guidelines we maintain.

 

A significant amount of our earnings are generated outside of the U.S.A. and are indefinitely reinvested in non-U.S.A. subsidiaries, resulting in the majority of our cash being held outside the U.S.A. which are available for use by our non-U.S.A. operations. If these funds were repatriated to the U.S.A. or used for U.S.A. operations, the amounts would be subject to U.S.A. tax. Therefore, as we continue to accumulate earnings outside of the U.S.A, we intend to use the cash generated from U.S.A operations as well as borrowings to meet our U.S.A. cash needs. Should we require more capital in the U.S.A. than is generated by our U.S.A. operations, we could elect to repatriate earnings from our non-U.S.A. subsidiaries, seek additional borrowing capacity or to raise additional capital in the U.S.A. These alternatives could result in higher effective income tax rates, additional interest expense or other dilution of our earnings.

 

 
-17-

 

 

Cash Flow

 

Cash Flow from Operating Activities

 

Our primary source of funds has historically been cash provided by operating activities. In the first three-months of 2016, cash provided by operations totaled approximately $93,000, due primarily to net income of $488,000, adjusted by non-cash depreciation and amortization of $689,000, and a decrease in inventory of $165,000 and an increase in accounts payable of $399,000 which was offset by an increase in accounts receivable of $1.2 million, a decrease in accrued compensation of $966,000 due primarily to severance and annual bonus payments.

 

In the first three-months of 2015, cash provided by operations totaled approximately $794,000, due primarily to net income of $908,000, non-cash depreciation and amortization of $605,000, an increase in deferred revenue of $890,000, and an decrease in accounts payable of $1.3 million. These changes in cash from operating activities were partially offset from a decrease in inventories of $441,000, and a reduction in accounts receivable of $209,000.

 

Cash Flow from Investing Activities

 

Cash used in investing activities totaled approximately $102,000 in the first three-months of 2016 due primarily to the purchase of property, plant and equipment and intangible assets totaling $137,000.

 

Cash used in investing activities totaled approximately $501,000 in the first three-months of 2015 due primarily to the purchase of property, plant and equipment and intangible assets totaling $458,000.

 

Cash Flow from Financing Activities 

 

Cash used in financing activities in the first three-months of 2016 totaled approximately $578,000 due primarily to dividends paid of $637,000 offset by the payments less proceeds for the line of credit of $41,000.

 

Cash used in financing activities in the first three-months of 2015 totaled approximately $772,000 due primarily to a reduction of our term notes payable of $232,000 and dividends paid of $632,000. These uses of cash were partially offset by the proceeds received from stock option exercises of $106,000.

 

Although we have repurchased shares of our common stock in the past, we currently are not authorized by our Board of Directors to make repurchases of our common stock. Under the credit agreement with the Bank, we are able to purchase up to $2.0 million in shares of our common stock without the Bank’s approval.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements, as defined by the rules and regulations of the SEC, that have or are reasonably likely to have a material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. As a result, we are not materially exposed to financing, liquidity, market or credit risk that could arise if we had engaged in these arrangements.

 

Recently Issued Accounting Guidance

 

Revenue from Contracts with Customers

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2014-09, Revenue from Contracts with Customers. The requirements of the new standard are effective for annual reporting periods beginning after December 15, 2017, and interim periods within those annual periods. We are currently evaluating the impact of this guidance on our results of operations and financial position.

 

 
-18-

 

 

Inventory – Simplifying the Measurement of Inventory

 

In July 2015, the FASB issued ASU 2015-11, Inventory – Simplifying the Measurement of Inventory. The requirements of the new standard are effective for annual reporting periods beginning after December 15, 2016, and interim periods within those annual periods. We are currently evaluating the impact of this guidance on our results of operations and financial position.

 

Leases

 

In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 requires that lease arrangements longer than 12 months result in an entity recognizing an asset and liability. The new guidance is effective for interim and annual periods beginning after December 15, 2018. Early adoption of the update is permitted. We are currently evaluating the impact of this guidance on our results of operations and financial position.

 

Stock Compensation

 

In March 2016, The FASB issued ASU 2016-09, Compensation-Stock Compensation. ASU 2016-09 is in an effort to reduce cost and complexity and improve the accounting for share-based payment awards issued to employees for public and private companies. The new guidance is effective for interim and annual periods beginning after December 15, 2016. Early adoption of the update is permitted. We are currently evaluating the impact of this guidance on our results of operations and financial position.

 

Critical Accounting Policies

 

Our most critical accounting policies, which are those that require significant judgment, include policies related to revenue recognition, allowance for doubtful accounts, accrual for excess and obsolete inventories, recoverability of long-lived assets, goodwill and income taxes. An in-depth description of these can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Management has not changed the method of calculating and using estimates and assumptions in preparing our condensed consolidated financial statements in accordance with generally accepted accounting principles. There have been no changes in the policies for our accounting estimates for the quarter ended March 31, 2016.

 

Forward-Looking Statements

 

This report contains forward-looking statements that involve future events, our future performance and our future operations and actions. In some cases you can identify forward-looking statements by the use of words such as “may,” “should,” “anticipate,” “believe,” “expect,” “plan,” “future,” “intend,” “could,” “estimate,” “predict,” “hope,” “potential,” “continue,” or the negative of these terms or other similar expressions. These forward-looking statements are only our predictions and involve numerous assumptions, risks and uncertainties. These forward-looking statements may be contained in the notes to our consolidated financial statements and elsewhere in this report, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Some of the factors known to us that could cause our actual results to differ materially from what we have anticipated in our forward-looking statements are described below.

 

 

Decline in overall economic or business conditions;

 

Failure to comply with our bank covenants;

 

 

 
-19-

 

 

 

Failure to develop new products and applications, or acquire complementary businesses and productions;

 

Failure to attract and retain qualified managerial and technical personal;

 

The impact of technological changes that could render our products obsolete;

 

Risks inherent in operating internationally and selling and shipping our products and purchasing our products and components internationally;

 

The impact of cash held outside the United States;

 

The impact of the Euro value decline against the United States dollar;

 

Fluctuations in foreign currency exchange rates and interest rates;

 

Highly competitive nature of the markets in which we sell our products and the introduction of competing products;

 

Reliance on patents, domestic trademarks laws, trade secrets and contractual provisions;

 

Exposure to the fluctuation of our common stock market price;

 

Compliance with securities laws and regulations;

 

Exposure to risks in evaluation of internal control;

 

Increases in prices for raw materials;

 

Effects of introducing new products into the marketplace with minimal acceptance concurrently;

 

Declining oil prices adversely affecting our revenue in Industrial Analyzers and Other segment;

 

Unanticipated charges and unknown cost savings through a realignment plan

 

Item 3.     Quantitative and Qualitative Disclosures About Market Risk

 

Foreign Currency Exchange Risk

 

Today, nearly 68 percent of our consolidated revenue is generated from international customers. In our U.S. operations, we invoice most of these customers in U.S, dollars, so we do not have significant exposure to foreign currency transaction risk. In our European based operations, we have some exposure to foreign currency fluctuations as we invoice our customers primarily in euros, Danish krone and U.S. dollars. From time to time we use foreign exchange hedging contracts to reduce our exposure in these transactions. We also pay a number of our employees, international suppliers and service providers in their local currency which exposes us to transaction gain or loss. These have not resulted in material amounts in the past. Our foreign operations expose us to foreign currency exchange risk when the Danish krone, euro and yuan currency results of operations are translated to U.S. dollars. Except for the 2015 period, we historically have not experienced any material foreign currency translation gains or losses. During the three months ended March 31, 2016, we recognized a foreign translation loss of $9,000.

 

Our investments in foreign subsidiaries translated into U.S. dollars are not hedged. Any changes in foreign currency exchange rates are reflected as a foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in shareholders’ equity, and would not impact our net income.

 

 
-20-

 

 

Item 4.      Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 (Exchange Act), as amended, is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered in this Quarterly Report on Form 10-Q. Based on the evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of such period, to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that material information relating to our Company and our consolidated subsidiaries is made known to management, including our Chief Executive Officer and Chief Financial Officer, particularly during the period when our periodic reports are being prepared.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during our quarter ended March 31, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 
-21-

 

 

PART II.     OTHER INFORMATION

 

Item 1.          Legal Proceedings

 

None.

 

Item 1A.      Risk Factors

 

We are affected by risks specific to us as well as factors that affect all businesses operating in a global market. The significant factors known to us that could materially adversely affect our business, financial condition or operating results or could cause our actual results to differ materially from our expectations are described in our annual report on Form 10-K for the fiscal year ended December 31, 2015 under the heading “Part I – Item 1A. Risk Factors.” There has been no material change in those risk factors.

 

 

Item 2.         Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

 

Unregistered Sales of Equity Securities

 

We did not sell any equity securities of MOCON, Inc. during the three-month period ended March 31, 2016 that were not registered under the Securities Act of 1933.

 

 

Issuer Repurchases of Equity Securities

 

We did not repurchase any equity securities of MOCON, Inc. during the three-months ended March 31, 2016.

 

Item 3.         Defaults Upon Senior Securities

 

None.

 

Items 4.       Mine Safety Disclosures

 

None.

 

Item 5.         Other Information

 

 
-22-

 

 

Item 6.      Exhibits

 

The following exhibits are being filed or furnished with this quarterly report on Form 10-Q:

 

Exhibit

No.

 

 

Description

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

     

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

     

32.1

 

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

     

32.2

 

Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

     

101

 

The following materials from MOCON, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, formatted in XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Income, (iii) the unaudited Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the unaudited Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements. (filed herewith)

     

 

 
-23-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MOCON, INC.

 
     
     

Date: May 6, 2016

/s/ Robert L. Demorest

   
 

Robert L. Demorest

 
 

Chairman, President and Chief

 
 

Executive Officer

 
 

(Principal Executive Officer)

 
     
     

Date:  May 6, 2016

/s/ Elissa Lindsoe

   
 

Elissa Lindsoe

 
 

Chief Financial Officer

 
 

(Principal Financial and Accounting Officer)

 

 

 
-24-

 

   

MOCON, INC.

QUARTERLY REPORT ON FORM 10-Q

QUARTER ENDED MARCH 31, 2016

 

EXHIBIT INDEX

 

Exhibit

No.

 

 

Description

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

     

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

     

32.1

 

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

     

32.2

 

Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

     

101

 

The following materials from MOCON, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, formatted in XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Income, (iii) the unaudited Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the unaudited Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.

 

-25-

Mocon (NASDAQ:MOCO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mocon Charts.
Mocon (NASDAQ:MOCO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mocon Charts.